semaglutide discontinuation Adults with obesity who discontinue semaglutide, tirzepatide achieve minimal weight loss 💉 GLP-1 medications are changing

So a lot of those questions and answers Ive been working on for quite awhile from basic science and clinical side

According to the FDA, GLP-1 weight loss medications are indicated for adults with a body mass index (BMI) of 30 or greater, or for adults with a BMI of 27 or greater who also have at least one weight-related health condition such as hypertension, type 2 diabetes, or high cholesterol

At the 10mg format, this precision is delivered with the research capacity required for full dose-response protocols, multi-arm experimental designs, and the single-batch consistency that longitudinal studies demand

That keeps you from stacking five things and guessing what worked